On August 11, 2026, IceCure Medical Ltd. announced that Vincent Chun Hung Chan resigned from its Board of Directors, effective August 14, 2026, with no disagreements cited. The Board appointed David Salton as an independent Class II director until the 2027 annual general meeting, assigning him to the Compensation, Audit, and Financial Statement Examination Committees. Salton currently serves as CEO of AnchorMesh Ltd. and holds prior board roles at SHL Telemedicine, ARAN Research & Development, and InterCure Inc. IceCure Medical Ltd. operates in the medical device industry, specializing in cryoablation therapies for cancer treatment.
